Eisuke Booka

Hamamatsu University School of Medicine

Papers

2

Total Citations

37

H-Index

2

About

Dr. Eisuke Booka is a leading surgical oncologist whose research focuses on refining treatment strategies for esophageal cancer, with a particular emphasis on the interplay between surgical outcomes and long-term cancer prognosis. His major contributions center on understanding how postoperative complications—especially infectious events like pulmonary issues and anastomotic leaks—can paradoxically influence cancer recurrence and survival. In his highly cited 2021 study (24 citations), Dr. Booka demonstrated that these complications are not merely short-term setbacks but may alter the trajectory of cancer progression, thereby informing more tailored perioperative management and adjuvant therapy decisions. He has also been at the forefront of comparing surgical techniques, notably evaluating robot-assisted minimally invasive esophagectomy (RAMIE) against thoracoscopic and open approaches in a landmark institutional study (13 citations). This work provides critical evidence on the safety and efficacy of robotic surgery, helping to guide the adoption of less invasive methods. Through these investigations, Dr. Booka is shaping a more nuanced, complication-aware approach to esophageal cancer care, directly impacting how surgeons balance operative risk with oncologic outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
37
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Infectious Complications after Esophagectomy for Esophageal Cancer on Cancer Prognosis and Treatment Strategy
24 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Hamamatsu University School of Medicine

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago